Century Therapeutics (IPSC)
NASDAQ:IPSC
US Market
Holding IPSC?
Track your performance easily

Century Therapeutics (IPSC) Financial Statements

137 Followers

Century Therapeutics Financial Overview

Century Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.038; its P/E ratio is -0.65; Century Therapeutics is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.43. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 791.00K$ 771.00K$ 268.00K$ 148.00K$ 99.00K
Gross Profit$ 791.00K$ 771.00K$ 268.00K$ 148.00K$ 99.00K
EBIT$ -31.23M$ -31.18M$ -40.27M$ -32.13M$ -32.20M
EBITDA$ -27.94M$ -26.61M$ -36.72M$ -28.78M$ -28.93M
Net Income Common Stockholders$ -31.23M$ -31.21M$ -39.40M$ -32.72M$ -33.29M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 198.11M$ 196.40M$ 172.74M$ 169.50M$ 156.40M
Total Assets$ 388.62M$ 416.45M$ 360.69M$ 397.55M$ 417.16M
Total Debt$ 50.84M$ 52.71M$ 46.66M$ 45.53M$ 40.83M
Net Debt$ -147.28M$ -143.69M$ -126.08M$ -123.97M$ -115.56M
Total Liabilities$ 192.93M$ 194.34M$ 175.94M$ 178.32M$ 169.59M
Stockholders Equity$ 195.69M$ 222.10M$ 184.75M$ 219.23M$ 247.57M
Cash Flow-
Free Cash Flow$ -27.51M$ -27.60M$ -27.21M$ -16.91M$ -23.75M
Operating Cash Flow$ -28.33M$ -27.33M$ -26.23M$ -13.65M$ -19.25M
Investing Cash Flow$ 39.20M$ -33.86M$ 18.60M$ 4.22M$ 6.97M
Financing Cash Flow$ 273.00K$ 56.70M$ -356.00K$ 300.00K$ -10.12M
Currency in USD

Century Therapeutics Earnings and Revenue History

Century Therapeutics Debt to Assets

Century Therapeutics Cash Flow

Century Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis